Flo

Flo offers an app that tracks women’s cycles to effectively predict ovulation dates. The app also offers solutions for motherhood and menopause. Flo uses artificial intelligence (AI) based algorithms to improve cycle prediction and track symptoms, which users can proactively address through necessary health insights, offered by the company.

Flo offers both free and subscription-based versions of the app, with the latter including features such as unlimited access to health assistants, customer support, daily health tips, and expert content. The app operates in more than 20 languages and features over 100 medical experts on its platform as of September 2021. At the time, the app had tracked over 1 billion menstrual cycles and had recorded over 200 million app downloads—even being crowned as the most downloaded health app across the Apple App store in 2020. As of September 2021, 27.7 million pregnancies were reported on Flo, and 95% of its users have experienced an improvement in their well-being.

The company anticipated achieving USD 100 million in annual run rate by the end of 2021. As of August 2021, the number of active subscribers between ages 15 and 49 stood at 1.5 million, a 4x growth from the year before. By September that year, the company also reported that it employed 350 people and served 43 million monthly active users across the US, UK, and Europe.

In September 2021, the company raised USD 50 million (GBP 36.2 million) in a Series B funding round co-led by VNV Global and Target Global. The latest round valued the company at USD 800 million—a more than three-fold increase from the USD 230-million valuation it fetched during its Series A raise in June 2019. The company was expected to use the funding to enhance its personalization offering in order to provide users with advanced menstrual cycle insights and health patterns, invest in research partnerships with universities, and expand the headcount by 200, including 100 new roles in product, medical, and engineering in the UK.